A generic SNOMED-CT concept has been created for the COVID-19 non-replicating vector vaccine group (the parent concept in which the AstraZeneca, COVISHIELD and Janssen vaccines fall under):
- ConceptID: 29061000087103
- FSN: Vaccine product containing only non-replicating viral vector encoding protein of Severe acute respiratory syndrome coronavirus 2 (medicinal product)
- PT: COVID-19 non-replicating vector vaccine
- Syn: Vaccine product containing only non-replicating viral vector encoding protein of Severe acute respiratory syndrome coronavirus 2 | COVID-19 non-replicant vector vaccine
The concept is in scope for the next CVC release. It has been created in the CA Edition and is in scope for the March CA Edition publication. It will also be sent to SI for candidate in the July 2021 INT release. The full RFC can be viewed here: informs.infoway-inforoute.ca/browse/SCT-11026?filter=-2 (note that you must register for an InfoCentral account and request access to Informs).
Please don't hesitate to let me know if you have any questions.
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.
Generic concept created: COVID-19 non-replicating vector vaccine
Print
Email
Twitter